Haoxi Health (HAO) CFO Li Dongxue submits initial Form 3 ownership

Rhea-AI Filing Summary

Haoxi Health Technology Ltd officer Li Dongxue, the company’s Chief Financial Officer, filed an initial Form 3 reporting beneficial ownership. The data provided shows no reportable transactions, holdings, or derivative positions, indicating this is a baseline regulatory disclosure rather than a trading event.

Key Figures

Buy transactions reported: 0 transactions Sell transactions reported: 0 transactions Derivative transactions reported: 0 transactions +1 more

4 metrics

Buy transactions reported 0 transactions Form 3 transactionSummary buyCount

Sell transactions reported 0 transactions Form 3 transactionSummary sellCount

Derivative transactions reported 0 transactions Form 3 transactionSummary derivativeTransactionCount

Net buy/sell direction neutral Form 3 transactionSummary netBuySellDirection

Key Terms

Form 3, beneficial ownership, Chief Financial Officer, derivative securities

4 terms

Form 3 regulatory

"filed an initial Form 3 reporting beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial Form 3 reporting beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Chief Financial Officer financial

"serves as Chief Financial Officer of Haoxi Health Technology Ltd"

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

derivative securities financial

"no reportable transactions, holdings, or derivative positions"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 04/02/2026 - 08:47 PM Learn about SEC filing dates

FAQ

What does the Haoxi Health (HAO) Form 3 filing by Li Dongxue show?

The Form 3 filing shows that Chief Financial Officer Li Dongxue has filed an initial statement of beneficial ownership in Haoxi Health Technology Ltd. The provided data lists no reportable transactions, holdings, or derivative securities, making this a routine compliance disclosure.

Who is the reporting person in the Haoxi Health (HAO) Form 3?

The reporting person is Li Dongxue, who serves as Chief Financial Officer of Haoxi Health Technology Ltd. The filing identifies this role explicitly and confirms officer status, but shows no associated share transactions or derivative positions in the supplied data snapshot.

Does the Haoxi Health (HAO) Form 3 show any insider share transactions?

No, the Form 3 data shows zero buy, sell, acquisition, or disposition transactions for Li Dongxue. All transaction-related counts, including exercises, gifts, tax withholding, and restructurings, are reported as zero, indicating no trading activity in this specific disclosure record.

Are there any derivative securities reported for Li Dongxue in Haoxi Health (HAO)?

The provided Form 3 information lists an empty derivativeSummary and zero derivative transactions. This means no options, warrants, or other derivative positions are reported for Li Dongxue in this particular filing, based on the available structured data snapshot.

Is the Haoxi Health (HAO) Form 3 filing considered a significant event for investors?

This Form 3 appears to be a routine compliance filing establishing baseline beneficial ownership for CFO Li Dongxue. With no reported transactions or holdings in the data provided, it does not represent a notable insider buy or sell event for investors.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Li Dongxue

(Last) (First) (Middle)

ROOM 902, UNIT 1, 9TH FLOOR

NO.6A CHAOYANGMENWAI STREET

(Street)

BEIJING BEIJING 100020

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Haoxi Health Technology Ltd [ HAO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Dongxue Li	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)